Literature DB >> 27915016

Injectable supramolecular hydrogel formed from α-cyclodextrin and PEGylated arginine-functionalized poly(l-lysine) dendron for sustained MMP-9 shRNA plasmid delivery.

Qianming Lin1, Yumeng Yang1, Qian Hu1, Zhong Guo1, Tao Liu2, Jiake Xu3, Jianping Wu4, Thomas Brett Kirk4, Dong Ma5, Wei Xue6.   

Abstract

Hydrogels have attracted much attention in cancer therapy and tissue engineering due to their sustained gene delivery ability. To obtain an injectable and high-efficiency gene delivery hydrogel, methoxypolyethylene glycol (MPEG) was used to conjugate with the arginine-functionalized poly(l-lysine) dendron (PLLD-Arg) by click reaction, and then the synthesized MPEG-PLLD-Arg interacted with α-cyclodextrin (α-CD) to form the supramolecular hydrogel by the host-guest interaction. The gelation dynamics, hydrogel strength and shear viscosity could be modulated by α-CD content in the hydrogel. MPEG-PLLD-Arg was confirmed to bind and deliver gene effectively, and its gene transfection efficiency was significantly higher than PEI-25k under its optimized condition. After gelation, MMP-9 shRNA plasmid (pMMP-9) could be encapsulated into the hydrogel matrix in situ and be released from the hydrogels sustainedly, as the release rate was dependent on α-CD content. The released MPEG-PLLD-Arg/pMMP-9 complex still showed better transfection efficiency than PEI-25k and induced sustained tumor cell apoptosis. Also, in vivo assays indicated that this pMMP-9-loaded supramolecular hydrogel could result in the sustained tumor growth inhibition meanwhile showed good biocompatibility. As an injectable, sustained and high-efficiency gene delivery system, this supramolecular hydrogel is a promising candidate for long-term gene therapy. STATEMENT OF SIGNIFICANCE: To realize the sustained gene delivery for gene therapy, a supramolecular hydrogel with high-efficiency gene delivery ability was prepared through the host-guest interaction between α-cyclodextrin and PEGylated arginine-functionalized poly(l-lysine) dendron. The obtained hydrogel was injectable and biocompatible with adjustable physicochemical property. More importantly, the hydrogel showed the high-efficiency and sustained gene transfection to our used cells, better than PEI-25k. The supramolecular hydrogel resulted in the sustained tumor growth inhibition meanwhile keep good biocompatibility. As an injectable, sustained and high-efficiency gene delivery system, this supramolecular hydrogel is a promising candidate in long-term gene therapy and tissue engineering.
Copyright © 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Arginine; Poly(l-lysine) dendrimer; Supramolecular hydrogels; Sustained gene delivery

Mesh:

Substances:

Year:  2016        PMID: 27915016     DOI: 10.1016/j.actbio.2016.11.062

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  8 in total

Review 1.  Nanoscale bioconjugates: A review of the structural attributes of drug-loaded nanocarrier conjugates for selective cancer therapy.

Authors:  Wenjie Zhang; Reza Taheri-Ledari; Fatemeh Ganjali; Fereshte Hassanzadeh Afruzi; Zoleikha Hajizadeh; Mahdi Saeidirad; Fateme Sadat Qazi; Amir Kashtiaray; Samin Sadat Sehat; Michael R Hamblin; Ali Maleki
Journal:  Heliyon       Date:  2022-06-02

2.  Redox-responsive PEGylated self-assembled prodrug-nanoparticles formed by single disulfide bond bridge periplocymarin-vitamin E conjugate for liver cancer chemotherapy.

Authors:  Huiyun Zhang; Wenqian Xu; Emmanuel Omari-Siaw; Yingkun Liu; Baoding Chen; Deyu Chen; Jiangnan Yu; Ximing Xu
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

3.  Biocompatible supramolecular pseudorotaxane hydrogels for controllable release of doxorubicin in ovarian cancer SKOV-3 cells.

Authors:  Caixia Li; Hanxue Li; Jiahao Guo; Liang Li; Xiaowei Xi; Yanyan Yu
Journal:  RSC Adv       Date:  2020-01-02       Impact factor: 4.036

4.  Anti-GPC3 antibody-modified sorafenib-loaded nanoparticles significantly inhibited HepG2 hepatocellular carcinoma.

Authors:  Xiaolong Tang; Longzhou Chen; Amin Li; Shiyu Cai; Yinci Zhang; Xueke Liu; Zhenyou Jiang; Xinkuang Liu; Yong Liang; Dong Ma
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

5.  Stimuli-responsive drug delivery systems for head and neck cancer therapy.

Authors:  Jingou Liang; Bina Yang; Xuedong Zhou; Qi Han; Jing Zou; Lei Cheng
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

Review 6.  Injectable Hydrogels for Cancer Therapy over the Last Decade.

Authors:  Giuseppe Cirillo; Umile Gianfranco Spizzirri; Manuela Curcio; Fiore Pasquale Nicoletta; Francesca Iemma
Journal:  Pharmaceutics       Date:  2019-09-19       Impact factor: 6.321

Review 7.  α-Cyclodextrin-Based Polypseudorotaxane Hydrogels.

Authors:  Adrian Domiński; Tomasz Konieczny; Piotr Kurcok
Journal:  Materials (Basel)       Date:  2019-12-28       Impact factor: 3.623

8.  A cationic polymeric prodrug with chemotherapeutic self-sensibilization co-delivering MMP-9 shRNA plasmid for a combined therapy to nasopharyngeal carcinoma.

Authors:  Tao Liu; Xidong Wu; Shaohua Chen; Peina Wu; Hong Han; Hongbin Zhang; Junzheng Li; Guanxue Li; Siyi Zhang
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.